TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Total liabilities 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) total liabilities at each fiscal year-end, per SEC filings.
$32.8BFY2025 · since FY2016: $58.1B → $32.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $32.8B | -2.3% |
| FY2024 | $33.6B | -4.9% |
| FY2023 | $35.4B | -0.2% |
| FY2022 | $35.4B | -2.8% |
| FY2021 | $36.4B | -8.0% |
| FY2020 | $39.6B | -6.7% |
| FY2019 | $42.4B | -5.5% |
| FY2018 | $44.9B | -13.5% |
| FY2017 | $51.9B | -10.7% |
| FY2016 | $58.1B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice